Top compounds associated with response to CLDND2


Feature Type Standardized
Nominal ANOVA
mRNA quizartinib CTRPv2 pan-cancer AAC 0.061 0.1
mRNA PLX4720 CCLE pan-cancer AAC 0.074 0.1
mRNA Irinotecan gCSI pan-cancer AAC -0.082 0.1
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.054 0.1
mRNA KH-CB19 CTRPv2 pan-cancer AAC -0.073 0.1
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.058 0.1
mRNA MS-275 CTRPv2 pan-cancer AAC -0.051 0.1
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA sotrastaurin CTRPv2 pan-cancer AAC -0.062 0.1
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.058 0.1
Download CSV